Search Results - "Branagan AR"

Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.

Authors: Gustine JN Attar N Puliafito BR et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Apr 22; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 22.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia.

Authors: Sarosiek S Castillo JJ Hunter ZR et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Apr; Vol. 67 (5), pp. 989-996. Date of Electronic Publication: 2026 Jan 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Authors: Castillo JJ Branagan AR Guijosa A et al.

Source: American journal of hematology [Am J Hematol] 2026 Jun; Vol. 101 (6), pp. 1255-1263. Date of Electronic Publication: 2026 Mar 15.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Authors: Sun H Sklavenitis-Pistofidis R Liu S et al.

Source: Blood [Blood] 2026 May 14; Vol. 147 (20), pp. 2298-2314.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Case 13-2026: A 76-Year-Old Woman with Fatigue, Rash, and Kidney Failure.

Authors: Cortazar FB Sise ME Rapalino O et al.

Source: The New England journal of medicine [N Engl J Med] 2026 Apr 30; Vol. 394 (17), pp. 1737-1748.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE; In Process

Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells.

Authors: Pizzarella D Kofides A Hatcher JM et al.

Source: Blood advances [Blood Adv] 2026 Jul 14; Vol. 10 (13), pp. 4450-4454.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom macroglobulinemia.

Authors: Tsakmaklis N Hunter ZR Liu X et al.

Source: Blood advances [Blood Adv] 2026 Mar 24; Vol. 10 (6), pp. 1954-1958.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T.

Authors: Gustine JN Scaringi JA Bauer F et al.

Source: Leukemia [Leukemia] 2026 Feb; Vol. 40 (2), pp. 440-443. Date of Electronic Publication: 2025 Dec 19.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma.

Authors: Nakamoto-Matsubara R Nardi V Horick N et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Dec 23; Vol. 14 (1), pp. 224. Date of Electronic Publication: 2024 Dec 23.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells.

Authors: Munshi M Liu X Kofides A et al.

Source: British journal of haematology [Br J Haematol] 2024 Nov; Vol. 205 (5), pp. 1866-1872. Date of Electronic Publication: 2024 Sep 18.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.

Authors: Branagan AR Mo C Lei M et al.

Source: Blood advances [Blood Adv] 2025 Sep 23; Vol. 9 (18), pp. 4568-4579.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis.

Authors: Guijosa A Ramirez-Gamero A Sarosiek S et al.

Source: Blood advances [Blood Adv] 2025 Sep 23; Vol. 9 (18), pp. 4705-4715.

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury.

Authors: Kim EB Malespini JE Lei M et al.

Source: Blood advances [Blood Adv] 2025 Jul 08; Vol. 9 (13), pp. 3129-3135.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma.

Authors: Gustine JN Branagan AR Cirstea DD et al.

Source: Blood advances [Blood Adv] 2025 Jun 24; Vol. 9 (12), pp. 3026-3030.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment.

Authors: Blumenberg V Puliafito BR Graham CE et al.

Source: Blood [Blood] 2025 Jun 05; Vol. 145 (23), pp. 2788-2793.

Publication Type: Case Reports; Letter

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors.

Authors: Castillo JJ Autore F Berinstein NL et al.

Source: Seminars in hematology [Semin Hematol] 2025 Apr; Vol. 62 (2), pp. 113-119. Date of Electronic Publication: 2025 Apr 08.

Publication Type: Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0404514 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8686 (Electronic) Linking ISSN: 00371963 NLM ISO Abbreviation: Semin Hematol Subsets: MEDLINE

Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy.

Authors: Nelson TA Murthy NK Martinez-Lage M et al.

Source: Neurology [Neurology] 2025 Mar 25; Vol. 104 (6), pp. e213393. Date of Electronic Publication: 2025 Feb 20.

Publication Type: Journal Article; Published Erratum

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE; PubMed not MEDLINE

Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.

Authors: Yee AJ Laubach JP Campagnaro EL et al.

Source: Blood advances [Blood Adv] 2025 Mar 11; Vol. 9 (5), pp. 1163-1170.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.

Authors: Miller KC Johnson PC Abramson JS et al.

Source: Blood cancer journal [Blood Cancer J] 2022 Nov 01; Vol. 12 (10), pp. 146. Date of Electronic Publication: 2022 Nov 01.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy.

Authors: Nelson TA Murthy NK Martinez-Lage M et al.

Source: Neurology [Neurology] 2024 Nov 12; Vol. 103 (9), pp. e209929. Date of Electronic Publication: 2024 Oct 04.

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE